BIOSENSING INSTRUMENT, INC.
Label-free biosensor instrument for measuring ligand binding kinetics to transmembrane proteins using nano-oscillator array technology
- Sector
- Medtech
- Total capital
- $11M
- Federal grants
- $11M
- 20 awards · 2014–2025
- Rank in peer group#12 of 112
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 7 pending · first 2020
- Rank in peer group#26 of 112
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Plasmonic Scattering Microscopy for high-throughput in-situ quantification of molecular binding kinetics on single cells$933K
- Federal grantHealth and Human S · Phase II · Spotting-free Nano-Oscillator Array for Quantification of Virion Displayed Membrane Protein Binding Kinetics$350K
- Federal grantHealth and Human S · Phase II · Plasmonic Scattering Microscopy for high-throughput in-situ quantification of molecular binding kinetics on single cells$296K
- Federal grantHealth and Human S · Phase II · Critical angle reflection imaging for label-free quantification of molecular interactions$832K
- Federal grantHealth and Human S · Phase II · Critical angle reflection imaging for label-free quantification of molecular interactions$283K
- Federal grantHealth and Human S · Phase II · Development of a charge-sensitive optical detection system for high-throughput study of small molecules$829K
- Federal grantHealth and Human S · Phase II · Critical angle reflection imaging for label-free quantification of molecular interactions$825K
Show 13 earlier federal awards
- Federal grantHealth and Human S · Phase II · Critical angle reflection imaging for label-free quantification of molecular interactions$255K
- Federal grantHealth and Human S · Phase II · Development of a charge-sensitive optical detection system for high-throughput study of small molecules$840K
- Federal grantHealth and Human S · Phase II · Nano-Oscillator Arrays for Sensitive Plasmonic Detection of Molecular Interactions and Reactions$720K
- Federal grantHealth and Human S · Phase II · An Integrated Microarray Printing and Detection System$600K
- Federal grantHealth and Human S · Phase II · Nano-Oscillator Arrays for Sensitive Plasmonic Detection of Molecular Interactions and Reactions$701K
- Federal grantHealth and Human S · Phase II · Nano-Oscillator Arrays for Sensitive Plasmonic Detection of Molecular Interactions and Reactions$222K
- Federal grantHealth and Human S · Phase II · An Integrated Microarray Printing and Detection System$600K
- Federal grantHealth and Human S · Phase II · An Integrated Microarray Printing and Detection System$600K
- Federal grantHealth and Human S · Phase II · Electrochemically-Enhanced Plasmonic Imaging for Quantitative Proteomics$282K
- Federal grantHealth and Human S · Phase II · An Integrated Microarray Printing and Detection System$350K
- Federal grantHealth and Human S · Phase II · Electrochemically-Enhanced Plasmonic Imaging for Quantitative Proteomics$561K
- Federal grantHealth and Human S · Phase II · An Integrated Microarray Printing and Detection System$350K
- Federal grantHealth and Human S · Phase II · Electrochemically-Enhanced Plasmonic Imaging for Quantitative Proteomics$560K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 112 peers
Line = medianMedtech · Instrument
- Federal grants#12 · top 11%
- Granted patents#26 · top 23%
- Linked publications#9 · top 8%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 9- PendingMethods For Rapid Analyte Concentration Analysis For Multiple SamplesUSPTOApplication 18130396
- PendingSystem And Method For Analyzing Molecular Interactions On Living Cells Using Biosensor TechniquesUSPTOApplication 17736389
- GrantedSurface Plasmon Resonance Imaging System And Method For Measuring Molecular InteractionsUSPTOUS 11,327,014
Show all 9 patent records
- Methods For Rapid Analyte Concentration Analysis For Multiple SamplesOct 5, 2023 · Application 18130396Pending
- System And Method For Analyzing Molecular Interactions On Living Cells Using Biosensor TechniquesAug 18, 2022 · Application 17736389Pending
- Surface Plasmon Resonance Imaging System And Method For Measuring Molecular InteractionsMay 10, 2022 · US 11,327,014Granted
- Surface Plasmon Resonance Imaging System And Method For Measuring Molecular InteractionsOct 20, 2020 · US 10,809,194Granted
- Quick validation method for binding kinetic analysisOct 3, 2019 · Application 15910840Pending
- Methods For Rapid Analyte Concentration Analysis For Multiple SamplesApplication 63326909Pending
- Methods For Rapid Analyte Concentration Analysis For Multiple SamplesApplication PCTUS2023017351Pending
- System And Method For Analyzing Molecular Interactions On Living Cells Using Biosensor TechniquesApplication PCTUS2023020881Pending
- Surface Plasmon Resonance Imaging System And Method For Measuring Molecular InteractionsApplication PCTUS2019034087Pending
Recent research by its founders
- Dual‐Function Piezo‐Photocatalytic Systems for Sustainable Hydrogen Evolution and Environmental Remediation202513 cites
- Photogenerated charge carriers in photocatalytic materials for solar hydrogen evolution20258 cites
- Review and Analyze the Sources, Characteristics and Composition of Electronic Waste20252 cites
Related companies, and why
- HAWAII INTEGRATED ANALYTICS LLCSimilar federal contract value in Medtech · null in contracts
- NanoxSimilar federal contract value in Medtech · null in contracts
- LEBRUN LABS, LLCSimilar federal contract value in Medtech · null in contracts
- ADVANCED GENOMIC TECHNOLOGY, LLCSimilar federal contract value in Medtech · null in contracts
- PLUMERIA THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
- CACTUS MEDICAL,LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .